BlackRock’s Tobira Therapeutics, Inc. Common Stock TBRA Stock Holding History

BlackRock’s Portfolio TBRA Stock Details TBRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-875	Closed	-$35K	–	3878
2016 Q3	$35K	Buy	875 +598	+216%	+$6.67K	﹤0.01%	3121
2016 Q2	$3K	Buy	+277	New	+$2.58K	﹤0.01%	3619
2014 Q2	–	Sell	-1	Closed	–	–	3281
2014 Q1	$0	Buy	+1	New	+$70	﹤0.01%	3205

BlackRock's TBRA Position: Q4 2016 in Review

BlackRock sold out of Tobira Therapeutics, Inc. Common Stock (TBRA) in Q4 2016, closing a stake of 875 shares — an estimated $35K sold.

BlackRock first reported a position in TBRA in Q1 2014 and held it in 3 quarters. The position peaked at $35K in Q3 2016. 0 funds tracked by Wall St. Rank hold TBRA as of Q4 2016.

BlackRock reported no remaining Tobira Therapeutics, Inc. Common Stock position as of Q4 2016 after selling out during the quarter.
BlackRock sold 875 Tobira Therapeutics, Inc. Common Stock shares in Q4 2016, an estimated $35K.
BlackRock first reported a position in Tobira Therapeutics, Inc. Common Stock in Q1 2014 and held it in 3 quarters.
BlackRock's Tobira Therapeutics, Inc. Common Stock position peaked at $35K in Q3 2016.
0 funds tracked by Wall St. Rank held Tobira Therapeutics, Inc. Common Stock as of Q4 2016.

Based on BlackRock's 13F filing for Q4 2016, filed 10 Feb 2017.